Home/Filings/4/0001144204-19-003872
4//SEC Filing

Bendheim Daniel M 4

Accession 0001144204-19-003872

CIK 0001069899other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 9:07 PM ET

Size

20.0 KB

Accession

0001144204-19-003872

Insider Transaction Report

Form 4
Period: 2019-01-28
Bendheim Daniel M
DirectorExec. VP, Corporate Strategy
Transactions
  • Sale

    Class A Common Stock

    2019-01-28$31.55/sh2,500$78,8750 total
  • Exercise/Conversion

    Class A Common Stock

    2019-01-28$11.83/sh+2,500$29,5752,500 total
  • Exercise/Conversion

    Class A Common Stock

    2019-01-29$11.83/sh+4,890$57,8494,890 total
  • Sale

    Class A Common Stock

    2019-01-29$31.32/sh4,890$153,1550 total
  • Exercise/Conversion

    Class A Common Stock

    2019-01-30$11.83/sh+2,390$28,2742,390 total
  • Sale

    Class A Common Stock

    2019-01-30$31.15/sh2,390$74,4490 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2019-01-282,5007,280 total
    Exercise: $11.83From: 2013-03-01Exp: 2019-02-28Class A Common Stock (2,500 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2019-01-294,8902,390 total
    Exercise: $11.83From: 2013-03-01Exp: 2019-02-28Class A Common Stock (4,890 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2019-01-302,3900 total
    Exercise: $11.83From: 2014-03-01Exp: 2019-02-28Class A Common Stock (2,390 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.19 to $32.08, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.08 to $31.73, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.04 to $31.30, inclusive.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother

Related Parties

1
  • filerCIK 0001601576

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:07 PM ET
Size
20.0 KB